The development of cisplatin drug resistance remains a chief concern in ovarian cancer
chemotherapy. β-Elemene is a natural plant product with broad-spectrum antitumor activity …

Abstract β-Elemene is a promising new plant-derived drug with broad-spectrum anticancer
activity. It also increases cisplatin cytotoxicity and enhances cisplatin sensitivity in resistant …

Elemene is a natural antitumor plant drug. However, the effect of elemene on cell growth in
ovarian cancer is unknown. In this study, we show that β-elemene inhibited the proliferation …

Abstract β-Elemene is a new anticancer compound extracted from the Chinese medicinal
herb Rhizoma zedoariae. We have shown previously that β-elemene increases cisplatin …

β-Elemene, originally derived from plants, has been recently investigated as a new
anticancer agent. The purpose of this study was to explore the efficacy and mechanisms of …

Cisplatin-based combination treatment is the most effective systemic chemotherapy for
bladder cancer; however, resistance to cisplatin remains a significant problem in the …

Objectives β-Elemene, a natural compound extracted from over 50 different Chinese
medicinal herbs and plants, has been effective in the treatment of hyperplastic and …

Cisplatin is one of the most potent chemotherapeutic agents for the treatment of many types
of solid tumours. Nevertheless, it is not the first‐line drug for prostate cancer chemotherapy …

Abstract β-Elemene, a new plant-derived anticancer agent with low toxicity, has been
reported to be effective in the treatment of leukemia and solid tumors. In the current study …

The development of effective agents for overcoming platinum chemoresistance in lung
carcinoma continues to have high priority. We have demonstrated recently that β-elemene, a …